A trial of NAV 001 for the treatment of autoimmune disorders
Latest Information Update: 02 Dec 2016
At a glance
- Drugs NAV 001 (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
- 02 Dec 2016 New trial record
Latest Information Update: 02 Dec 2016